...
首页> 外文期刊>BMC Nephrology >Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
【24h】

Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study

机译:在透析患者与没有癌症的透析患者之间的生命结束时的医疗结果和医疗保健成本的比较:基于国家的基于国家的研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Palliative care has improved the quality of end-of-life (EOL) care and lowered the health care cost of cancer, and these benefits should be extended to patients with other serious illnesses including end-stage kidney disease. We evaluated the quality of EOL care, survival probabilities, and health care costs for dialysis patients in their last month of life. We conducted a population-based study and analyzed data from Taiwan's Longitudinal Health Insurance Database, which contains claims information of patient medical records, health care costs, and insurance system exit dates (our proxy for death between 2006 and 2011). Data of 1177 adult patients who died of chronic hemodialysis or peritoneal dialysis were investigated. The mean age of these patients was 69.7?±?11.9?years, and 585 (49.7%) were women. Some patients with dialysis received cardiopulmonary resuscitation (66.9%), died in a hospital (65.0%), or were admitted to an intensive care unit (51.0%) in the last month of life. We further classified these patients into two groups, namely dialysis with cancer (DC) (n?=?149) and dialysis without cancer (D) (n?=?1028). Only 19 dialysis patients received palliative care, and the proportion of patients receiving palliative care was higher in the DC group than in the D group (11.4% vs. 0.2%). The mean health care costs per person during the final month of life was similar between the DC and D groups (USD 2755?±?259 vs. USD 2827?±?88). Multivariate logistic regression showed that the DC group had lower odds of receiving cardiopulmonary resuscitation (CPR) (OR: 0.39, CI?=?0.26-0.56, p??25?days) (OR: 1.52, CI?=?1.01-2.29, p?=?0.0046), and higher odds of being hospitalized more than once (OR: 2.26, CI?=?1.42-3.59, p?=?0.001) than the D group in the last month of life after adjustments. DC patients received hospice care more frequently, received CPR less frequently, and had similar health care costs. DC patients also had a higher risk of a hospital stay that lasted more than 25?days and more than one hospitalization compared with D patients in the final month of life.
机译:姑息治疗提高了生活结束(EOL)护理的质量,降低了癌症的医疗保健成本,并且这些益处应扩展到其他严重疾病,包括终级肾病。我们在生命的最后一个月评估了透析患者的EOL护理,存活概率和医疗费用的质量。我们进行了一项以人口为基础的研究,并分析了台湾纵向健康保险数据库的数据,其中包含患者医疗记录,医疗费用和保险系统退出日期的索赔信息(我们在2006年至2011年之间的死亡代表)。研究了1177名死亡慢性血液透析或腹膜透析的成年患者的数据。这些患者的平均年龄为69.7?±11.9?岁月,585(49.7%)是女性。一些透析患者患有心肺复苏(66.9%),在医院死亡(65.0%),或者在最后一个月内被录取为重症监护单位(51.0%)。我们进一步将这些患者分为两组,即透析,即癌症(DC)(N?= 149)和透析而没有癌症(D)(n?=?1028)。只有19名透析患者接受了姑息治疗,并且在DC组中接受姑息治疗的患者比例高于D组(11.4%vs.0.2%)。每人在最终月份的平均医疗保健成本在DC和D组之间相似(2755 u?±259 Vs.2827?±88)。多变量逻辑回归显示,DC组接受心肺复苏的几率较低(CPR)(或:0.39,CI = 0.26-0.56,P ?? 25?天)(或:1.52,CI?=?1.01-2.29 ,p?= 0.0046),越来越多的几率超过一次(或:2.26,CI?=?1.42-3.59,P?= 0.001)在调整后的最后一个月的生命中的D组。 DC患者更频繁地接受了临终关怀护理,频繁收到CPR,并具有相似的医疗费用。 DC患者的住院风险较高,持续超过25岁以下的时间,与D患者在最后一个月的生命中相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号